Advertisement

Topics

MultiGEN Diagnostics Inc. Company Profile

02:36 EST 22nd November 2017 | BioPortfolio


News Articles [499 Associated News Articles listed on BioPortfolio]

Stryker gets FDA nod for MultiGen 2 RF generator system

Medical technology firm Stryker has secured approval from the US Food and Drug Administration (FDA) for its MultiGen 2 radiofrequency (RF) generator system.

Stryker's MultiGen 2 Radiofrequency Generator Receives FDA 510(k) Clearance

  Life Sciences Jobs   ...

Stryker's MultiGen 2 Radiofrequency Generator Wins FDA 510(k) Clearance

  Life Sciences Jobs   ...

Co-Diagnostics, Synbiotics launch joint venture CoSara Diagnostics in India

Co-Diagnostics, a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced the recent incorporation of CoSara Diagnostics, a ...

IPO nets $6.4mm for Co-Diagnostics

Molecular diagnostics start-up Co-Diagnostics Inc. netted $6.4mm through its initial public offering of 1.18mm common shares at $6 each on the Nasdaq.

FDA clears Stryker's radiofrequency energy generator

The FDA has granted Stryker 510(k) clearance for its MultiGen 2 radiofrequency energy generator, a device intended for use in -More- 

Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay

Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB)...

EKF Diagnostics and Ortho Clinical Diagnostics collaborate on a new diabetic ketoacidosis assay

Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, and EKF Diagnostics (EKF) today announced an agreement that allows Ortho customers to access to Beta-Hydroxybutyrate (BHB) ...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [221 Associated PubMed Articles listed on BioPortfolio]

Component resolved diagnostics for hymenoptera venom allergy.

Component-resolved diagnostics makes use of defined allergen molecules to analyse IgE-mediated sensitizations at a molecular level. Here, we review recent studies on the use of component-resolved diag...

Comprehensive genetic study of cystic fibrosis in Slovak patients in 25 years of genetic diagnostics.

Cystic fibrosis (CF) has one of the longest histories in hereditary disease molecular diagnostics. However, identification of causative mutations in the CFTR gene is complicated by over two thousand c...

Advances in point-of-care technologies for molecular diagnostics.

Advances in miniaturization, nanotechnology, and microfluidics, along with developments in cloud-connected point-of-care (POC) diagnostics technologies are pushing the frontiers of POC devices toward ...

Local enamel demineralization diagnostics and treatment.

The article describes focal enamel demineralization - the most common disease of teeth hard tissues. Local and general factors of this pathological process advent and development were described. The m...

Molecular diagnostics of ALK-positive lung cancer.

ALK translocation is the 3rd most frequent genetic aberration in lung adenocarcinoma, and several inhibitors are now clinically available in first and second line settings. Accordingly, molecular diag...

Clinical Trials [163 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Companies [898 Associated Companies listed on BioPortfolio]

Bio-ID Diagnostic Inc

Bio-ID Diagnostic Inc is a biotech R&D company that uses novel DNA based technologies to enhance the molecular diagnosis of disease, and the process of drug discovery.Presently, the company has two su...

MultiGEN Diagnostics Inc.

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

More Information about "MultiGEN Diagnostics Inc." on BioPortfolio

We have published hundreds of MultiGEN Diagnostics Inc. news stories on BioPortfolio along with dozens of MultiGEN Diagnostics Inc. Clinical Trials and PubMed Articles about MultiGEN Diagnostics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MultiGEN Diagnostics Inc. Companies in our database. You can also find out about relevant MultiGEN Diagnostics Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record